ID: ALA4288819

Max Phase: Preclinical

Molecular Formula: C24H29N3O4

Molecular Weight: 423.51

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccccc1C(=O)N(CC(=O)NC1CCCCC1)Cc1ccc(C(=O)NO)cc1

Standard InChI:  InChI=1S/C24H29N3O4/c1-17-7-5-6-10-21(17)24(30)27(16-22(28)25-20-8-3-2-4-9-20)15-18-11-13-19(14-12-18)23(29)26-31/h5-7,10-14,20,31H,2-4,8-9,15-16H2,1H3,(H,25,28)(H,26,29)

Standard InChI Key:  HYPFRFUBFJLNJM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 423.51

Molecular Weight (Monoisotopic): 423.2158

AlogP: 3.21

#Rotatable Bonds: 7

Polar Surface Area: 98.74

Molecular Species: NEUTRAL

HBA: 4

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 9.05

CX Basic pKa:

CX LogP: 3.05

CX LogD: 3.04

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.47

Np Likeness Score: -1.45

References

1. Diedrich D, Stenzel K, Hesping E, Antonova-Koch Y, Gebru T, Duffy S, Fisher G, Schöler A, Meister S, Kurz T, Avery VM, Winzeler EA, Held J, Andrews KT, Hansen FK..  (2018)  One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.,  158  [PMID:30245402] [10.1016/j.ejmech.2018.09.018]

Source

Source(1):

• Scientific Literature